Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9362695 | Otolaryngology - Head and Neck Surgery | 2005 | 4 Pages |
Abstract
By using the treatment protocol and definition of hearing recovery of this study, intratympanic dexamethasone does not result in significant hearing improvement for patients with profound ISSNHL. There is a possible trend for improved hearing results if intratympanic treatment is performed within 11 days of onset of hearing loss.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Robert A. (FACS),